Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 100

1.

Fettemboli er en utdatert diagnose.

Dahl OE, Reikerås O, Pripp AH, Engesæter LB.

Tidsskr Nor Laegeforen. 2018 Feb 19;138(4). doi: 10.4045/tidsskr.17.0946. Print 2018 Feb 20. Norwegian. No abstract available.

PMID:
29460584
Free Article
2.

Similar Clinical Outcomes with Preoperative and Postoperative Start of Thromboprophylaxis in THA: A Register-based Study.

Borgen PO, Pripp AH, Dybvik E, Leistad L, Dahl OE, Reikerås O.

Clin Orthop Relat Res. 2017 Sep;475(9):2245-2252. doi: 10.1007/s11999-017-5419-1. Epub 2017 Jun 22.

PMID:
28643079
3.

Thrombin Generation in Patients With Suspected Venous Thromboembolism.

Wexels F, Dahl OE, Pripp AH, Seljeflot I.

Clin Appl Thromb Hemost. 2017 Jul;23(5):416-421. doi: 10.1177/1076029617700999. Epub 2017 Mar 24.

PMID:
28335612
4.

Postoperative start compared to preoperative start of low-molecular-weight heparin increases mortality in patients with femoral neck fractures.

Leer-Salvesen S, Dybvik E, Dahl OE, Gjertsen JE, EngesæTer LB.

Acta Orthop. 2017 Feb;88(1):48-54. doi: 10.1080/17453674.2016.1235427. Epub 2016 Sep 23.

5.

D-Dimer and prothrombin fragment 1 + 2 in urine and plasma in patients with clinically suspected venous thromboembolism.

Wexels F, Seljeflot I, Pripp AH, Dahl OE.

Blood Coagul Fibrinolysis. 2016 Jun;27(4):396-400. doi: 10.1097/MBC.0000000000000461.

PMID:
26595215
6.

Oral dabigatran etexilate versus enoxaparin for venous thromboembolism prevention after total hip arthroplasty: pooled analysis of two phase 3 randomized trials.

Eriksson BI, Dahl OE, Rosencher N, Clemens A, Hantel S, Feuring M, Kreuzer J, Huo M, Friedman RJ.

Thromb J. 2015 Nov 17;13:36. doi: 10.1186/s12959-015-0067-8. eCollection 2015.

7.

The population attributable risk of nutrition and lifestyle on hip fractures.

Pripp AH, Dahl OE.

Hip Int. 2015 May-Jun;25(3):277-81. doi: 10.5301/hipint.5000229. Epub 2015 Apr 23. Review.

PMID:
25907388
8.

Arterial and venous thrombosis following trauma and major orthopedic surgery: molecular mechanisms and strategies for intervention.

Dahl OE, Harenberg J, Wexels F, Preissner KT.

Semin Thromb Hemost. 2015 Mar;41(2):141-5. doi: 10.1055/s-0035-1544230. Epub 2015 Feb 17. Review.

PMID:
25703244
9.

Prothrombin fragment 1+2 in urine as a marker on coagulation activity in patients with suspected pulmonary embolism.

Wexels F, Dahl OE, Pripp AH, Seljeflot I, Borris LC, Haslund A, Gudmundsen TE, Lauritzen T, Lassen MR.

Thromb Res. 2014 Jul;134(1):68-71. doi: 10.1016/j.thromres.2014.04.011. Epub 2014 Apr 26.

PMID:
24824294
10.

The proportion of perioperative mortalities attributed to cemented implantation in hip fracture patients treated by hemiarthroplasty.

Pripp AH, Talsnes O, Reikerås O, Engesæter LB, Dahl OE.

Hip Int. 2014 Jul-Aug;24(4):363-8. doi: 10.5301/hipint.5000123. Epub 2014 Feb 11.

11.

Biomarkers of Coagulation and Fibrinolysis during Cemented Total Hip Arthroplasty with Pre- versus Postoperative Start of Thromboprophylaxis.

Borgen PO, Dahl OE, Reikeras O.

Thrombosis. 2013;2013:563217. doi: 10.1155/2013/563217. Epub 2013 Dec 16.

12.

Clinical venous thromboembolism following joint surgery: effect of extended thromboprophylaxis on its annual frequency and postoperative pattern over 22 years.

Dahl OE, Gudmundsen TE, Pripp AH, Aanesen JJ.

Clin Appl Thromb Hemost. 2014 Mar;20(2):117-23. doi: 10.1177/1076029613499820. Epub 2013 Oct 10.

PMID:
24113492
13.

Thrombin split products (prothrombin fragment 1 + 2) in urine in patients with suspected deep vein thrombosis admitted for radiological verification.

Wexels F, Haslund A, Dahl OE, Pripp AH, Gudmundsen TE, Laszlo F, Seljeflot I, Borris LC, Lassen MR.

Thromb Res. 2013 Jun;131(6):560-3. doi: 10.1016/j.thromres.2013.04.019. Epub 2013 May 13.

PMID:
23680105
14.

Update of the recommendations on biosimilar low-molecular-weight heparins from the Scientific Subcommittee on Control of Anticoagulation of the International Society on Thrombosis and Haemostasis.

Harenberg J, Walenga J, Torri G, Dahl OE, Drouet L, Fareed J; Subcommittee on Control of Anticoagulation, Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis.

J Thromb Haemost. 2013 Jul;11(7):1421-5. No abstract available.

15.

No difference in mortality between cemented and uncemented hemiprosthesis for elderly patients with cervical hip fracture. A prospective randomized study on 334 patients over 75 years.

Talsnes O, Hjelmstedt F, Pripp AH, Reikerås O, Dahl OE.

Arch Orthop Trauma Surg. 2013 Jun;133(6):805-9. doi: 10.1007/s00402-013-1726-5. Epub 2013 Mar 27.

PMID:
23532371
16.

Perioperative mortality in hip fracture patients treated with cemented and uncemented hemiprosthesis: a register study of 11,210 patients.

Talsnes O, Vinje T, Gjertsen JE, Dahl OE, Engesæter LB, Baste V, Pripp AH, Reikerås O.

Int Orthop. 2013 Jun;37(6):1135-40. doi: 10.1007/s00264-013-1851-3. Epub 2013 Mar 19.

17.

Bleeding definitions in orthopaedic VTE prophylaxis trials: a real need for standardization.

Dahl OE.

Thromb Res. 2012 Oct;130 Suppl 1:S32. doi: 10.1016/j.thromres.2012.08.268. No abstract available.

PMID:
23026656
18.

Interpretation of endpoints in a network meta-analysis of new oral anticoagulants following total hip or total knee replacement surgery.

Harenberg J, Marx S, Dahl OE, Marder VJ, Schulze A, Wehling M, Weiss C.

Thromb Haemost. 2012 Nov;108(5):903-12. doi: 10.1160/TH12-07-0482. Epub 2012 Sep 26.

PMID:
23014668
19.

Biochemical lung, liver and kidney markers and early death among elderly following hip fracture.

Talsnes O, Hjelmstedt F, Dahl OE, Pripp AH, Reikerås O.

Arch Orthop Trauma Surg. 2012 Dec;132(12):1753-8. doi: 10.1007/s00402-012-1611-7. Epub 2012 Sep 21.

PMID:
22996053
20.

Efficacy of delayed thromboprophylaxis with dabigatran: pooled analysis.

Eriksson BI, Dahl OE, Rosencher N, Clemens A, Hantel S, Kurth AA.

Thromb Res. 2012 Dec;130(6):871-6. doi: 10.1016/j.thromres.2012.08.315. Epub 2012 Sep 17.

PMID:
22995531

Supplemental Content

Loading ...
Support Center